Global /China /Healthcare /Drug Manufacturers - General /603139

Shaanxi Kanghui Pharmaceutical Co., Ltd.

603139

• SSE: 603139 • Delayed

36.30CNY -1.3%

5.36 USD

As of 14 June 2026, Shaanxi Kanghui Pharmaceutical Co., Ltd. has a market cap of $535.07M USD, ranking #14677 globally and #4559 in China. It ranks #1306 in the Healthcare sector, and #483 in the Drug Manufacturers - General industry.

Global Rank

14677

Country Rank

4559

Sector Rank

1306

Industry Rank

483

Key Stats

Market Cap

$535.07MUSD

3.63B CNY

Enterprise Value

$616.83MUSD

4.17B CNY

Revenue (TTM)

$75.74MUSD

513.23M CNY

EBITDA (TTM)

-$12.48MUSD

-84.47M CNY

Net Income (TTM)

-$27.13MUSD

-183.84M CNY

EBITDA Margin

-16%

Profit Margin

-36%

PS Ratio

7.1

PB Ratio

4.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yanling Wang open_in_new

Employees

906

Founded

1999

Website

sxkh.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.3%	2.8%	36%	53%	65%	80%	94%	128%	127%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603139 陕西康惠制药股份有限公司 A ISIN: CNE100002XT3 Shares Out.: Shares Outstanding: 99.88M¹ Shares Float: 55.841M² TV: TradingView: SSE: 603139 SA: Stock Analysis: SHA: 603139 YF: Yahoo Finance: 603139.SS GF: Google Finance: SHA: 603139 BA: Barron's: 603139 MS: Morningstar: XSHG: 603139	36.30 CNY	TV: TradingView: SSE: 603139 SA: Stock Analysis: SHA: 603139 YF: Yahoo Finance: 603139.SS GF: Google Finance: SHA: 603139 BA: Barron's: 603139 MS: Morningstar: XSHG: 603139

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shaanxi Kanghui Pharmaceutical Co., Ltd.

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular, tranquilizer, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company was founded in 1999 and is based in Xianyang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 10K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 9K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 142K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 102K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 67K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 60K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 54K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 51K%	20.5	Switzerland

chevron_leftBack